Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Anricofen

PreclinicalSmall molecule

TThe First Affiliated Hospital of Xinxiang Medical College

1

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q2 2028

N/ANot yet recruiting

Sedation

NCT07376577

Clinical

Trials by Indication[1]

Sedation1 trial

Efficacy and Safety of Anricofen Combined With Ciprofol for Deep Sedation in Elderly Patients Undergoing ERCP

Not yet recruiting·TThe First Affiliated Hospital of Xinxiang Medical College·N/A·NCT07376577·141 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Anricofen. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Anricofen compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Anricofen. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — The First Affiliated Hospital of Xinxiang Medical College company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Preclinical[1]
Company: TThe First Affiliated Hospital of Xinxiang Medical College

Related News